%0
Generic
%T
PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations.
%A De Bono, Johann S.
%A Fizazi, Karim
%A Saad, Fred
%A Shore, Neal D.
%A Roubaud, Guilhem
%A Ozguroglu, Mustafa
%A Penel, Nicolas
%A Matsubara, Nobuaki
%A Mehra, Niven
%A Procopio, Giuseppe
%A Kolinsky, Michael Paul
%A Nishimura, Kazuo
%A Feyerabend, Susan
%A Joung, Jae Young
%A Vogelzang, Nicholas J.
%A Carducci, Michael Anthony
%A Kang, Jinyu
%A Poehlein, Christian Heinrich
%A Wu, Wenting
%A Hussain, Maha H. A.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2020
%C American Society of Clinical Oncology (ASCO)